临床肺部感染评分在卒中相关性肺炎患者预后评估中的作用
Bi-level positive airway pressure respirator combined with aerosolization inhalation for the treatment of acute exacerbation of chronic obstructive pulmonary disease accompanied by type Ⅱ respiratory failure in the elderly
-
摘要: 目的:探讨临床肺部感染评分(CPIS)的变化对卒中相关性肺炎(SAP)患者的预后评估作用。方法:对183例SAP患者进行分析,记录出现SAP前3天及发病后第1、3、5、7天的CPIS,根据预后将患者分为存活组和病死组,比较2组CPIS的差异。结果:所有患者发病后CPIS均比发病前明显升高(P0.01);病死组发病后第1、3、5、7天与发病前3天的评分比较均明显升高(P0.01);存活组发病后第1、3、5天与发病前3天的评分比较均明显升高,第7天则较第1天显著下降(P0.01)。发病后第5天且CPIS;6分时,与存活患者相比病死率增高,其敏感性和特异性分别为91.3%和93.4%;CPIS与住院时间呈正相关关系(P0.01);当接受充分治疗后,发病后第5天CPIS轻度下降,而在没有充分的抗感染治疗时变化不明显。结论:CPIS作为肺部感染程度的量化指标可以很好地预测SAP患者的预后。Abstract: Objective: To explore the clinical effect of bi-level positive airway pressure (BiPAP ) respiraObjective: Tor combined with aerosolization inhalation in the treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)accompanied by type Ⅱ respiraObjective: Tory failure. Methods: Sixty-eight elderly patients with AECOPD accompanied by type Ⅱ respiraObjective: Tory failure were randomly divided inObjective: To control group(33 cases) and experiment group(35 cases). The control group were given the routine therapy such as antibiotics,cleaning the airway and BiPAP ventilaObjective: Tor,and the experiment group were given inhalation of terbutaline sulfate and budesonide in addition. The changes of the clinical manifestation, arterial blood gas analysis before and after treatmen, and the time of hospital stay were compared between the two groups. Results: The clinical manifestation and blood gas analysis of the two groups improved significantly after the therapy(P < 0. 05 Objective: To P < 0. 01) ; the average hospital stay of the experiment group was much shorter than that of the control group(P < 0. 01). Conclusions: BiPAP ventilation combined with aerosolization inhalation is effective on elderly patients with AECOPD accompanied by type Ⅱ respiraObjective: Tory failure.